Nothing said here yet.
to join the conversation.
| Opaleye Management Inc. | Buy | 14,973 | $123.3K | Fri, Oct 23 |
| Opaleye Management Inc. | Buy | 17,117 | $142.5K | Thu, Oct 22 |
| Opaleye Management Inc. | Buy | 14,283 | $117.6K | Fri, Oct 16 |
| Opaleye Management Inc. | Buy | 22,657 | $191.0K | Thu, Oct 15 |
| Opaleye Management Inc. | Buy | 19,050 | $165.6K | Thu, Oct 1 |
| Opaleye Management Inc. | Buy | 13,426 | $113.7K | Fri, Sep 25 |
| Opaleye Management Inc. | Buy | 18,337 | $157.1K | Thu, Sep 24 |
| Opaleye Management Inc. | Buy | 53,029 | $454.6K | Wed, Sep 16 |
| Opaleye Management Inc. | Buy | 27,141 | $228.0K | Wed, Sep 16 |
| Opaleye Management Inc. | Buy | 3,375 | $28.8K | Tue, Sep 15 |
| Opaleye Management Inc. | Buy | 40,373 | $351.1K | Mon, Sep 14 |
| Wills Robert JamesDirector | Buy | 10,000 | $96.2K | Fri, Aug 21 |
Dallas, Texas--(Newsfile Corp. - August 17, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG).
The fair value price target for Alpha Cognition has shifted from about US$14.67 to US$16.75, which places the stock in a higher valuation range than before.
ZUNVEYL revenue surged 71% sequentially as repeat prescriber rates hit 76%.
Alpha Cognition Inc. (ACOG) delivered earnings and revenue surprises of -2.56% and +41.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alpha Cognition Inc. (ACOG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Alpha Cognition Inc. (NASDAQ:ACOG) is one of the 10 High Growth Stocks Insiders Are Buying. On July 10, 2026, Raymond James analyst Ryan Deschner initiated coverage of Alpha Cognition Inc. (NASDAQ:ACOG) with an Outperform rating and $20 price target.